phenytoin / Generic mfg.  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

20 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
phenytoin / Generic mfg.
ACTRN12624001326583: Efficacy of levetiracetam versus phenytoin in children with convulsive status epilepticus, Single blinded Randomized controlled trial

Not yet recruiting
N/A
134
 
Dr Hina Parvaiz- Medical Teaching Institute Lady Reading Hospital Peshawar
Status epilepticus
 
 
NCT00004403: Randomized Study of Albendazole in Patients With Epilepsy Due to Neurocysticercosis

Completed
N/A
120
US
albendazole, dexamethasone, phenytoin
Johns Hopkins University
Epilepsy, Cysticercosis
 
03/02
NCT00333931: Pilot Trial of Neural Correlates of Response to Treatment of PTSD-Associated Impulsive Aggression

Unknown status
N/A
12
US
Phenytoin, Cognitive Behavioral Therapy
Michael E. DeBakey VA Medical Center, Dr. Thomas A. Kent, Dr. Stacey Holmes, Dr. Su Bailey, Dr. Mark Kunik, Dr. Melinda Stanley
Impulsive Aggression, Posttraumatic Stress Disorder
 
 
NCT00226538: Prediction of Drug Interactions With CYP2C9 Substrates

Completed
N/A
16
RoW
Phenytoin, Rifampicin, Diclophenac, Fluconazole
Hadassah Medical Organization
Healthy Volunteers
 
 
NCT00823264: Phenytoin and Multidose Activated Charcoal

Completed
N/A
17
US
Activated Charcoal, Charcoal
Emory University
Phenytoin Toxicity
07/10
01/12
NCT00739154: Protective Effect of Phenytoin on Glaucoma

Unknown status
N/A
200
RoW
Rabin Medical Center
Primary Open Angle Glaucoma, Secondary Open Angle Glaucoma, Narrow-Angle Glaucomas, Normal Tension Glaucoma
11/10
12/10
NCT01390909: Clinical and Economic Burden of Uncontrolled Epilepsy: Analyses From a Medicaid Database and a Private Health Plan Database

Completed
N/A
12386
US
Anti-epileptic drug (AED), Mysoline® is a registered trademark of Valeant Pharmaceuticals, Neurotin® is registered trademark of Pfizer, Inc, Vimpat® is a registered trademark of UCB Pharma, Tegretol® is a registered trademark of Novartis Pharmaceuticals, Trileptal® is a registered trademark of Novartis Pharmaceuticals, Sabril® is a registered trademark of Lundbeck Inc, Felbatol® is a registered trademark of MedPointe, Topamax® is a registered trademark of Ortho-McNeill-Janssen Pharmaceuticals, Depakote® is a registered trademark of Abbott Laboratories, Zonegran® is a registered trademark of Dainippon Pharmaceutical C. Ltd., Gabatril® is a registered trademark of Cephalon, Keppra® is registered trademark of UCB Pharma, Zarontin® is a registered trademark of Pfizer, Lamictal® is a registered trademark of GlaxoSmithKline, Luminal® is a registered trademark of Abbott Laboratories, Dilantin® is a registered trademark of Pfizer, Lyrica is registered trademark of Pfizer
GlaxoSmithKline
Epilepsy
01/11
01/11
NCT00774306: Antiepileptic Drugs and Vascular Risk Markers

Terminated
N/A
52
NA
phenytoin, Dilantin, Cerebyx (a phenytoin pro-drug), valproate, Depakote, Depacon, levetiracetam, Keppra
Thomas Jefferson University, National Institute of Neurological Disorders and Stroke (NINDS)
Subarachnoid Hemorrhage
06/12
06/12
NCT03269214: Use of Topical Phenytoin in Bisphosphonate-related Osteonecrosis of the Mandible

Completed
N/A
20
NA
Topical Phenytoin 5%
Shiraz University of Medical Sciences, Shahid Beheshti University of Medical Sciences
Osteonecrosis Due to Drugs, Jaw
10/16
03/17
NCT03096522: Randomized Trial on the Effect of Topical Phenytoin on Healing After Fistulotomy

Unknown status
N/A
38
RoW
Phenytoin 2% spray, Healosol, Anal fistulotomy, Lay open of anal fistula tract
Mansoura University
Anal Fistula
01/18
03/18
PADRE, NCT03632915: Pharmacokinetics of Antiepileptics in Patients on CRRT

Completed
N/A
18
US
Levetiracetam, Lacosamide, Phenytoin, Phenobarbital, Ketamine, Valproic Acid
University of Maryland, Baltimore
Acute Kidney Injury, Renal Insufficiency, Renal Failure, Pharmacokinetics
12/19
12/19
NCT00162461: Evaluation of CYP2C9 Activity

Unknown status
N/A
1200
RoW
Phenytoin single dose (300 mg)
Hadassah Medical Organization, United States - Israel Binational Science Foundation
Healthy
12/20
12/20
NCT00162474: Determinants of Warfarin Metabolism

Unknown status
N/A
600
RoW
Warfarin, Phenytoin
Hadassah Medical Organization
Healthy
12/20
12/20
NCT03712254: Phenytoin as Treatment for Acute Exacerbations of Trigeminal Neuralgia - a Prospective Systematic Study of 20 Patients

Completed
N/A
15
Europe
Fosphenytoin
Danish Headache Center
Trigeminal Neuralgia
10/21
11/21
NCT06067412: Efficacy of Phenytoin vs Levetiracetam in Status Epilepticus at Institute of Child Health,Faisalabad

Completed
N/A
70
RoW
Levetiracetam, Phenytoin
Shaheed Zulfiqar Ali Bhutto Medical University
Status Epilepticus
01/23
01/23
NCT05542589: Efficacy of Phenytoin Phonophoresis on Pressure Ulcer Healing

Completed
N/A
40
RoW
Phenytoin phonophoresis, Sham phenytoin phonophoresis
Cairo University
Pressure Ulcer
02/23
02/23
SUPER-CAT, NCT05756621: Dual Anti-glutamate Therapy in Super-refractory Status Epilepticus After Cardiac Arrest

Recruiting
N/A
80
Europe
Ketamine, Perampanel, Any anti-epileptic and anesthetic therapy, excluding Ketamine and Perampanel, Levetiracetam, Valproate, Phenytoin, Lacosamide, Topiramate, Propofol, Midazolam, Thiopental
University of Milano Bicocca, Azienda Ospedaliera San Gerardo di Monza, Azienda Ospedaliero-Universitaria di Modena, Azienda Ospedaliera Universitaria Integrata Verona, Ospedale Centrale Bolzano, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Azienda Ospedaliero-Universitaria Careggi, Azienda Ospedaliero-Universitaria di Parma, Santa Chiara Hospital, Ospedale M. Bufalini Cesena, Azienda Ospedaliera Brotzu, Istituto Di Ricerche Farmacologiche Mario Negri
Status Epilepticus, Cardiac Arrest
06/24
09/24
NCT06312254: Pharmacological Modulation of Peripheral Nerve Excitability

Not yet recruiting
N/A
20
Europe
Topical lidocaine 5%, Topical Phenytoin 10%, Topical Mepyramine 2%, Topical Placebo
Aalborg University
Peripheral Neuropathy
02/25
08/25
EPIPOP, NCT03196466: Population Pharmacokinetics of Antiepileptic in Pediatrics

Recruiting
N/A
1000
Europe
Valproic acid, carbamazepine, phenobarbital, phenytoin, levetiracetam, lamotrigine, topiramate, oxcarbazepine, stiripentol, clobazam, brivaracétam, felbamate, lacosamide, rufinamide, gabapentine, pregabaline, sultiame, tiagabine, vigabatrine, mesuximide, primidone, perampanel, ethosuximide, zonisamide, cannabidiol, genetic polymorphisms
Assistance Publique - Hôpitaux de Paris
Epilepsy
06/26
06/26
ELFURS, ChiCTR-OCH-14004616: Epilepsy Long-term Follow Up Registry Study

Recruiting
N/A
10400
 
carbamazepine ;sodium valproate ;lamotrigine ;topiramate ;oxcarbazepine ;levetiracetam ;gabapentin ;phenytoin ;phenobarbital ;clonazepam ;The antiepileptic drug 1 which will obtain marketing authorization in China in the future ;The antiepileptic drug 2 which will obtain marketing authorization in China in the future ;The antiepileptic drug 3 which will obtain marketing authorization in China in the future
The Department of Neurology, the First Affiliated Hospital of Wenzhou Medical University; The First Affiliated Hospital of Wenzhou Medical University, Wenzhou Medical Association
epilepsy
 
 

Download Options